Healthcare -
Biotechnology - NASDAQ - US
$ 2.11
9.33 %
$ 45.7 M
Market Cap
-0.73
P/E
ALRN - SHORT-TERM DEBT
Short-term Debt ALRN - Aileron Therapeutics, Inc.
48 K
LAST VALUE
-49.20%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR